PharmaVigilant introduced the latest version of its leading electronic Trial Master File system, I-Vault 2.6. The new enhancements addresses sponsors needs in customized workflow, bulk imports and improved reporting.
“Since its inception, I-Vault eTMF was designed to collect, manage, and organize all documents relating to a sponsors clinical trial or program.” I-Vault 2.6 now offers barcode recognition technology that will read barcode(s) from scanned files. By adding barcodes to our system generated Source Worksheets for example, users have the ability to do bulk or batch scans into I-Vault, which reads the file’s barcode and determines where the document should be placed within the system. This feature enhances our remote Source Document Verification service, streamlining the scanning process so documents are available in their correct placeholders sooner for EDC comparison.
With new OCR capability, I-Vault can now capture the contents of a scanned document and store it within the system. This allows users to convert their paper documents into searchable PDFs for text search purposes. This functionality also enables you to quickly locate content within the system based on a keyword search.
The enhancement to system notifications creates a more user based system with alerts and views of data catered to the authenticated user. When a notification is now created, it can be specified whether it should be sent to the user responsible for reviewing the document via email. This in turn eases the ability to monitor the TMF content across the life of the study.
I-Vault 2.6 also configures document dependencies to streamline the workflow. The Sponsor can now set the system to require a certain document or folder upon the upload or modified status of another document. Additionally, it can be specified whether certain document types require translations.
The digital signature feature of the system has been updated to allow I-Vault users to reach wholly electronic workflows through the authorization stage: Signatures are now embedded into the PDF so that information will never become disconnected from the document itself. This ensures that end users can easily verify and retain proof of identity and document integrity without costly, complicated, or proprietary software. The ability to add multiple signatures to a document is also supported.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.